First Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac Disease

First Wave BioPharma Inc FWBI has acquired ImmunogenX in an all-stock transaction with the combined company focused on advancing a gastrointestinal (GI) pipeline. First Wave BioPharma signed a non-binding term sheet in December to acquire ImmunogenX. James Sapirstein will continue to serve as…#firstwave #biopharmainc #firstwavebiopharma #jamessapirstein #jacksyage #sapirstein #gidivision #fda #immunogenx #niclosamide
Source: Reuters: Health - Category: Consumer Health News Source Type: news